Correlation Between Edgewise Therapeutics and Abeona Therapeutics
Can any of the company-specific risk be diversified away by investing in both Edgewise Therapeutics and Abeona Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Edgewise Therapeutics and Abeona Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Edgewise Therapeutics and Abeona Therapeutics, you can compare the effects of market volatilities on Edgewise Therapeutics and Abeona Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Edgewise Therapeutics with a short position of Abeona Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Edgewise Therapeutics and Abeona Therapeutics.
Diversification Opportunities for Edgewise Therapeutics and Abeona Therapeutics
0.79 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Edgewise and Abeona is 0.79. Overlapping area represents the amount of risk that can be diversified away by holding Edgewise Therapeutics and Abeona Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Abeona Therapeutics and Edgewise Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Edgewise Therapeutics are associated (or correlated) with Abeona Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Abeona Therapeutics has no effect on the direction of Edgewise Therapeutics i.e., Edgewise Therapeutics and Abeona Therapeutics go up and down completely randomly.
Pair Corralation between Edgewise Therapeutics and Abeona Therapeutics
Given the investment horizon of 90 days Edgewise Therapeutics is expected to generate 0.99 times more return on investment than Abeona Therapeutics. However, Edgewise Therapeutics is 1.01 times less risky than Abeona Therapeutics. It trades about 0.1 of its potential returns per unit of risk. Abeona Therapeutics is currently generating about 0.02 per unit of risk. If you would invest 1,688 in Edgewise Therapeutics on September 3, 2024 and sell it today you would earn a total of 1,612 from holding Edgewise Therapeutics or generate 95.5% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Significant |
Accuracy | 100.0% |
Values | Daily Returns |
Edgewise Therapeutics vs. Abeona Therapeutics
Performance |
Timeline |
Edgewise Therapeutics |
Abeona Therapeutics |
Edgewise Therapeutics and Abeona Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Edgewise Therapeutics and Abeona Therapeutics
The main advantage of trading using opposite Edgewise Therapeutics and Abeona Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Edgewise Therapeutics position performs unexpectedly, Abeona Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Abeona Therapeutics will offset losses from the drop in Abeona Therapeutics' long position.Edgewise Therapeutics vs. DiaMedica Therapeutics | Edgewise Therapeutics vs. Lyra Therapeutics | Edgewise Therapeutics vs. Centessa Pharmaceuticals PLC |
Abeona Therapeutics vs. Reviva Pharmaceuticals Holdings | Abeona Therapeutics vs. Athira Pharma | Abeona Therapeutics vs. Fortress Biotech | Abeona Therapeutics vs. ACADIA Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.
Other Complementary Tools
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
Money Managers Screen money managers from public funds and ETFs managed around the world | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like |